David J. Gaffin serves as the Executive Vice President, Chief Legal Officer, Chief Compliance Officer, and Secretary at Alkermes, a global biopharmaceutical company focused on developing innovative medicines for serious chronic diseases. In his multifaceted role, Gaffin is responsible for overseeing the company's legal affairs, ensuring compliance with regulatory standards, and providing strategic guidance to the executive team. His leadership is crucial in navigating the complex landscape of pharmaceutical law and regulation, ensuring that Alkermes remains at the forefront of ethical and legal standards in the industry. Before joining Alkermes, Gaffin amassed a wealth of experience in the legal and healthcare sectors. He holds a Juris Doctor degree from a prestigious law school and has practiced law for over two decades, specializing in corporate governance, intellectual property, and healthcare compliance. Prior to his current position, Gaffin held senior legal roles at several notable organizations, where he was instrumental in steering them through mergers and acquisitions, regulatory challenges, and strategic growth initiatives. His expertise in these areas has been pivotal in his contributions to Alkermes, where he has played a key role in the company's expansion and the successful launch of new therapeutic products. Under Gaffin's leadership, Alkermes has strengthened its compliance framework and enhanced its corporate governance practices. His strategic vision and dedication to ethical standards have been recognized both within the company and the broader industry. Gaffin's ability to balance legal acumen with business strategy has made him an invaluable asset to Alkermes, driving the company's mission to improve patient outcomes through innovative medicine.